Physician

Shilen N Patel, M.D.

According to 2025 Medicare claims, Shilen Patel, M.D. (NPI: 1811189681) practices hematology/oncology in the Tampa, FL market, with the plurality of this provider's patient population coming from Hernando, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 34608-1329.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 617 traditional Medicare patients, billed 187,305 HCPCS/CPT codes, and received $3,456,494 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 1,247 prescription claims across 223 beneficiaries totaling $2,980,472 in drug costs, led by Lenvima (Lenvatinib Mesylate). 2021 DME data shows 26 claims. Open Payments data shows 112 records totaling $2,862. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,450,272 to $3,456,494. Similarly, Part D prescription costs have risen steadily, from $435,778 to $2,980,472. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.0M$4.0M2015 Medicare payment: $1,450,272 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,213,136 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,849,110 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,971,611 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,208,730 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,479,960 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,857,919 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,036,734 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,334,419 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,456,494 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015702202,402$1,450,272
2016813205,278$2,213,136
2017760284,987$2,849,110
2018779283,352$2,971,611
2019765315,170$3,208,730
2020580208,519$2,479,960
2021589228,447$3,857,919
2022542222,143$4,036,734
2023605206,517$3,334,419
2024617187,305$3,456,494

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.5M$3.0M2015 Drug cost: $435,778 (USD; Tot_Drug_Cst)2016 Drug cost: $913,330 (USD; Tot_Drug_Cst)2017 Drug cost: $1,366,293 (USD; Tot_Drug_Cst)2018 Drug cost: $1,301,342 (USD; Tot_Drug_Cst)2019 Drug cost: $1,747,209 (USD; Tot_Drug_Cst)2020 Drug cost: $2,015,621 (USD; Tot_Drug_Cst)2021 Drug cost: $2,552,022 (USD; Tot_Drug_Cst)2022 Drug cost: $2,539,515 (USD; Tot_Drug_Cst)2023 Drug cost: $2,261,383 (USD; Tot_Drug_Cst)2024 Drug cost: $2,980,472 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015183780$435,778
2016135642$913,330
2017139830$1,366,293
2018147939$1,301,342
20191701,119$1,747,209
20201411,041$2,015,621
20211941,388$2,552,022
20221951,267$2,539,515
20231931,018$2,261,383
20242231,247$2,980,472

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$4.2K$8.3K2015 Medicare payment: $4,394 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $8,315 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $8,340 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $3,514 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $1,003 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $1,640 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $1,593 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R56$4,394
2016N/R12$8,315
2017N/R34$8,340
2018N/R38$3,514
2019N/R24$1,003
2020N/R16$1,640
2021N/R26$1,593
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more255811$67
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less106291$45
96372Injection of drug or substance under skin or into muscle167551$10
36415Insertion of needle into vein for collection of blood sample3781,093$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count3601,119$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LenvimaLenvatinib Mesylate21630$506,433
RevlimidLenalidomide27721$412,502
CabometyxCabozantinib S-Malate14420$259,544
ImbruvicaIbrutinib11308$180,608
BrukinsaZanubrutinib12360$176,821

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.112$2,862Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Shilen N. Patel, M.D.?

Tedicare shows public-source Medicare data for Shilen N. Patel, M.D. (NPI 1811189681), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shilen N. Patel, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Shilen N. Patel, M.D.?

Shilen N. Patel, M.D. is linked to FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (billing NPI 1760590962) in the available physician profile data.

Does Shilen N. Patel, M.D. have Open Payments data?

Shilen N. Patel, M.D. has 112 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.